Released by the Pandemic Response Accountability Committee, the report looks at data on test volume, turnaround, cost, and usage at six federal agencies.
More than $19 billion will be given through the CDC Epidemiology and Laboratory Capacity cooperative agreement to support testing, contact tracing, and surveillance.
Demand for SARS-CoV-2 testing sent lab revenues soaring while changes in patterns of patient care and regulations that could have impacts for years to come.
Amid increasing spending on genetic testing, there are more opportunities for bad actors to implement interstate, fraudulent billing schemes, according to OIG.
The instructions reverse an FDA decision to stop reviewing LDTs, but questions remain about how broadly they will be applied and how they will be implemented.
The company said that it will use the additional funding to complete product development in support of an FDA submission for its SensiTox B. anthracis Toxin Test.
